GlassScriptPhysician profile
Ralph N Vick
NPI 1659310639
$9,505.90
in general payments reported to CMS, 2019-2025
50 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $801 · 2021: $1,493 · 2022: $1,261 · 2023: $1,711 · 2024: $1,587 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,759.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,203.84 | 2019-2025 | Myrbetriq, Xtandi |
| Coloplast Corp | $1,125.36 | 2019-2025 | Titan, Speedicath |
| Boston Scientific Corporation | $786.24 | 2019-2025 | Ams 700, Axonics, Ams 800 Artificial Urinary Sphincter |
| Sumitomo Pharma America, INC. | $581.53 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $554.90 | 2019-2024 | Xiaflex, Aveed, Edex |
| Dendreon Pharmaceuticals LLC | $401.56 | 2020-2024 | Provenge |
| Abbvie INC. | $385.39 | 2019-2025 | |
| Pfizer INC. | $352.35 | 2019-2025 | |
| Neotract INC. | $327.74 | 2019-2020 | |
| Antares Pharma, INC. | $324.49 | 2019-2025 | Xyosted |
| Urogen Pharma, INC. | $270.52 | 2020-2025 | |
| Endo USA, INC. | $256.16 | 2024-2025 | Aveed, Xiaflex |
| Procept Biorobotics Corporation | $233.05 | 2022-2024 | Aquabeam System |
| Medtronic, INC. | $194.95 | 2022-2025 | Interstim |
| Laborie Medical Technologies Corp. | $178.06 | 2022-2025 | Injetak Adjustable Tip Needle 70cm |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $174.65 | 2021-2023 | Axonics |
| Immunitybio, INC. | $156.76 | 2025 | |
| Urovant Sciences INC | $146.32 | 2021-2022 | |
| 180 Medical, INC. | $143.50 | 2019-2024 | Gentlecath, Cure Catheter |
| Calyxo, INC. | $125.52 | 2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $120.60 | 2024 | Prolaris |
| Olympus America INC. | $118.82 | 2024-2025 | Itind System |
| Janssen Scientific Affairs, LLC | $104.28 | 2025 | |
| Ferring Pharmaceuticals INC. | $103.17 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $102.18 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $85.20 | 2023 | Keytruda, Lynparza, Welireg |
| Clarus Therapeutics INC. | $83.84 | 2020 | |
| Abc Home Medical Supply, INC. | $70.39 | 2023-2025 | |
| Halozyme INC | $66.33 | 2023 | |
| Hollister Incorporated | $65.04 | 2022-2024 | Infyna Chic, Onli, Vapro |
| Convatec INC. | $60.94 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $53.88 | 2023-2024 | Bard Urinary Drainage Bag |
| Agiliti Health, INC. | $47.75 | 2020 | |
| Teleflex LLC | $45.46 | 2022-2023 | Urolift |
| Smith+Nephew, INC. | $44.91 | 2020-2023 | Stravix Pl |
| Allergan, INC. | $41.45 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $38.15 | 2023-2025 | Pylarify |
| Rochester Medical Corporation | $35.45 | 2022 | |
| Janssen Biotech, INC. | $33.39 | 2020-2022 | |
| Tolmar, INC. | $33.31 | 2025 | Eligard, Jatenzo |
| Acerus Pharmaceuticals Corporation | $30.78 | 2020-2021 | |
| Heron Therapeutics, INC. | $28.13 | 2025 | Zynrelef |
| Zyla Life Sciences, INC. | $26.92 | 2019 | |
| Telix Pharmaceuticals | $25.46 | 2025 | Illuccix |
| Mimedx Group, INC. | $22.34 | 2025 | |
| Accord Healthcare, INC. | $22.28 | 2025 | |
| Photocure INC | $21.98 | 2024 | Cysview |
| Agiliti Surgical, INC. | $21.36 | 2022 | |
| Axogen | $14.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Vick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.